- Home
- LNW vs ARWR Comparison
LNW vs ARWR Comparison
Compare LNW & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNW
- ARWR
- Stock Information
- Founded
- LNW 1984
- ARWR 2003
- Country
- LNW United States
- ARWR United States
- Employees
- LNW N/A
- ARWR N/A
- Industry
- LNW EDP Services
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- LNW Technology
- ARWR Health Care
- Exchange
- LNW Nasdaq
- ARWR Nasdaq
- Market Cap
- LNW 6.7B
- ARWR 5.9B
- IPO Year
- LNW N/A
- ARWR 1993
- Fundamental
- Price
- LNW $79.71
- ARWR $38.08
- Analyst Decision
- LNW Buy
- ARWR Strong Buy
- Analyst Count
- LNW 8
- ARWR 8
- Target Price
- LNW $101.88
- ARWR $47.75
- AVG Volume (30 Days)
- LNW 1.4M
- ARWR 1.6M
- Earning Date
- LNW 11-05-2025
- ARWR 11-25-2025
- Dividend Yield
- LNW N/A
- ARWR N/A
- EPS Growth
- LNW 43.14
- ARWR N/A
- EPS
- LNW 4.59
- ARWR N/A
- Revenue
- LNW $3,221,000,000.00
- ARWR $572,976,000.00
- Revenue This Year
- LNW $7.18
- ARWR $21,287.22
- Revenue Next Year
- LNW $7.61
- ARWR N/A
- P/E Ratio
- LNW $17.35
- ARWR N/A
- Revenue Growth
- LNW 1.87
- ARWR 2816.20
- 52 Week Low
- LNW $69.56
- ARWR $9.57
- 52 Week High
- LNW $113.95
- ARWR $43.69
- Technical
- Relative Strength Index (RSI)
- LNW 55.32
- ARWR 51.02
- Support Level
- LNW $73.11
- ARWR $37.56
- Resistance Level
- LNW $86.00
- ARWR $40.94
- Average True Range (ATR)
- LNW 2.30
- ARWR 2.11
- MACD
- LNW 0.91
- ARWR -0.45
- Stochastic Oscillator
- LNW 58.20
- ARWR 15.79
About LNW Light & Wonder Inc.
Light & Wonder is principally an electronic gaming machine manufacturer, selling machines to pubs, clubs, and casinos. The firm is licensed in most jurisdictions allowing gambling globally. Light & Wonder is one of the three largest players in the space along with International Game Technology and Aristocrat Leisure. SciPlay, about one fourth of revenue, develops and distributes casual mobile games, principally in the social casino niche. The more nascent iGaming business sits between these two businesses, providing digital content and capabilities to real-money gaming providers.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.